Expanding access to microsurgery with the Symani robotic system
Official title: PRECISE: A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons
Run by MMI (Medical Microinstruments, Inc.) · NCT06725030 · Data updated 2026-11-12
This study will test the Symani robotic system to help surgeons sew very small blood vessels during free-flap and lymphovenous surgeries in adults.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 22 Years and up |
| Sex | All |
| Enrollment | 455 (estimated) |
| Sponsor | MMI (Medical Microinstruments, Inc.) Industry-sponsored |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 8 sites (Beverly Hills, California and 7 other locations) |
| Status | Recruiting |
| Started | September 22, 2025 |
| Main results expected | September 1, 2027 |
| Study ends | December 1, 2027 |
| Registry record updated | November 4, 2026 |
| Trial ID | NCT06725030 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 22 or older undergoing free tissue transfer for breast or extremity reconstruction or lymphovenous anastomosis with vessel sizes between 0.1 and 2.5 mm who can consent and attend follow-ups are ideal candidates.
✕Probably not a fit
Patients under 22, those with vessels outside the 0.1–2.5 mm range, or those not suitable for robotic-assisted microsurgery are unlikely to benefit from this device-based approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a post-market, observational, real-world registry of the Symani Surgical System used during open free tissue transfer and lymphovenous anastomosis procedures. Participants receive standard surgical care while surgeons use the device and investigators record intraoperative outcomes, device-related adverse events, and follow-up data. The primary effectiveness endpoint is the rate of intraoperative anastomosis patency at first attempt and the primary safety endpoint is freedom from device-related adverse events. Adults with clinical indication for microsurgical anastomosis of vessels between 0.1 and 2.5 mm who consent and can complete follow-up are eligible.
Why it matters
Potential benefit: If successful, the Symani system could increase first-attempt vessel patency and reduce technical strain on surgeons, potentially improving flap success and patient recovery.
How similar studies have gone: Small case series and early clinical reports have shown feasibility and acceptable safety for robot-assisted microsurgery, but large comparative trials remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Pre Operative Inclusion Criteria: 1. At least 22 years of age 2. Patient agrees to participate in the study, return for all required follow-up visits, complete all study procedures, and has willingly provided written informed consent after receiving all information related to the study, its requirements, and the robotic assisted procedure 3. Patient has a clinical indication for a microsurgical anastomosis of vessels between 0.1 and 2.5 mm in conjunction with open free-flap surgery of the breast or extremities and/or lymphovenous anastomosis surgery of the extremities 4. Investigator deems the candidate acceptable for free flap transfer surgery and/or lymphovenous anastomosis surgery with a robotic assisted microsurgical anastomosis in accordance with the Symani System's Instructions for Use (IFU) Cohort Specific Pre- Operative Inclusion Criteria: Free Tissue Transfer Surgery: N/A Lymphovenous Anastomosis Surgery 1. Swelling of one limb that is not completely reversed by elevation or compression 2. Stage I-II lymphedema at screening, based on the International Society of Lymphology (ISL) staging system 3. At least one of the following positive quantitative measurements: 1. Volumetry differential between affected limb and contralateral limb must be at least 10% of the other 2. Bioimpedance (L-Dex) differential, if feasible, between affected limb and contralateral limb of at least 10 units 4. Completion of a full course of complete decongestive therapy (CDT), according to ISL guidelines, for at least 12 weeks prior to screening, including use of compression garments for at least 12 weeks without change in regimen 5. Willingness to comply with recommended regimen of self-care, with consistent use of appropriately sized compression garments from screening through the entire study duration (through the 3-month follow-up visit). Pre-Operative Exclusion Criteria: 1. Patients who are incapable and/or unwilling to provide informed consent 2. Active systemic infection under treatment with intravenous antibiotics 3. Clinically significant cardiovascular, digestive, respiratory, endocrine, or central nervous system disorders, previous mental disorders, or other disorders that may significantly affect the data collection or the ability to comply with the protocol per the investigators discretion 4. Known history of significant bleeding, coagulopathy, or Von Willebrand's disease 5. Patients with implanted pacemaker 6. Planned vein graft 7. Currently receiving chemotherapy or radiation therapy 8. History of chronic kidney disease 9. History of chronic liver disease 10. Currently enrolled in any other investigational clinical studies that the investigator believes may impact patient safety or outcomes 11. Patients belonging to vulnerable populations, such as pregnant women, or ineligible to participate for other reasons in the judgement of the investigator Cohort Specific Pre-Operative Exclusion Criteria: Free Tissue Transplant Surgery: 1. Patients with buried flaps 2. Multiple flaps planned for the procedure Lymphovenous Anastomosis Surgery: 1. Patients \> 75 years of age 2. Patients with prior lymphatic reconstruction surgery 3. Patients with venous edema (arising from increased capillary filtration) 4. Patients with other medical conditions that could lead to acute limb edema, such as (but not limited to) acute venous thrombosis or heart failure 5. Patients with other medical conditions that could result in symptoms which overlap symptoms of lymphedema 6. Current infection in the affected limb 7. Patients who experience more than one episode of cellulitis in a six month period over the past two years 8. Current evidence or a history of malignancy within the past 6 months (if the participant has undergone cancer treatment, this must have been completed \> 6 months prior to enrollment) 9. Known iodine sensitivity 10. Patient's lymphatic disease is due to lipedema 11. Patients with bilateral lymphedema or lymphedema in multiple anatomical locations Intra Operative Exclusion Criteria: 1. Any presenting condition discovered intraoperatively that, in the opinion of the investigator, would make participating in this study not in the patient's best interest 2. The patient does not have at least one robotic stitch attempted during the index procedure
Where it's running
-
Cedars Sinai Medical Center
Beverly Hills, California, United States Recruiting -
Yale New Haven Hospital
New Haven, Connecticut, United States Recruiting -
Tampa General Hospital
Tampa, Florida, United States Recruiting -
Hackensack University Medical Center
Hackensack, New Jersey, United States Recruiting -
Erie County Medical Center
Buffalo, New York, United States Recruiting -
Icahn School of Medicine at Mount Sinai
New York, New York, United States Recruiting
Show 2 more locations
-
Cleveland Clinic
Cleveland, Ohio, United States Recruiting -
HCA Healthcare Trident Hospital
North Charleston, South Carolina, United States Recruiting
Study contacts
- Principal investigator: Bohdan Pomahac, MD — Yale New Haven Medical Center
- Study coordinator: Clinical Operations
- Email: clinical.ops@mmimicro.com
- Phone: 8336646276
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Symani robotic system for microsurgical and lymphatic anastomosis
This trial will try the Symani robot to help surgeons connect tiny blood and lymph vessels during free flap and lymphedema surgeries for adults who need microsurgical anastomosis.
-
Biological mesh reinforcement for digestive tract reconstruction
This study tests whether inserting a biological mesh during alimentary tract reconstruction can reduce bleeding and complications after digestive surgery.
-
Use of reconstructive microsurgery to treat lymphedema
This study tests whether reconstructive microsurgery, with or without the help of indocyanine green imaging, can help people with lymphedema feel and function better by improving lymphatic drainage.
-
Predicting lymphedema risk in inflammatory breast cancer patients using preoperative body impedance analysis
This study tests whether a preoperative bioimpedance test can help identify IBC patients who are at risk for developing lymphedema.
-
Boosted compression for lower limb edema
This study tests whether applying a multicomponent short-stretch bandage three times daily (boosted compression) helps reduce edema faster in people with chronic edema or lymphedema of the legs, compared with the standard single daily bandage.
-
ICG Fluorescence Imaging to Guide Head and Neck Free Flap Surgery
This trial tests whether using intraoperative indocyanine green (ICG) fluorescence imaging helps surgeons improve flap outcomes compared with standard assessments in adults undergoing head and neck free flap reconstruction.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.